Mr. Moti N Ramgopal, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 356 E Midway Rd, Fort Pierce, FL 34982 Phone: 772-464-9746 Fax: 772-464-9750 |
Miss Candice Theodora Joseph, M.D Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 356 E Midway Rd, Fort Pierce, FL 34982 Phone: 772-464-9746 Fax: 772-474-9750 |
Mariana R Loor, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2407 Okeechobee Rd, Fort Pierce, FL 34950 Phone: 772-468-9900 Fax: 772-468-2364 |
News Archive
The COVID-19 pandemic was predicted to and has had a major impact on the essential HIV health services in the South East Asia Region (SEAR), putting at risk the benefits accrued over the last two decades. Apart from the risks posed by the virus to the individual health of people living with HIV (PLHIV), COVID-19 has disrupted essential services causing considerable delays in the delivery of medicines and other health commodities.
Today, the Canadian Diabetes Association (CDA) and Juvenile Diabetes Research Foundation (JDRF) launched a national campaign to identify Canada's Diabetes Champions. This national celebration - held in honour of World Diabetes Day (November 14) - recognizes the ongoing commitment of millions of Canadians who build awareness of, and live with, diabetes in Canada.
In his latest Kaiser Health News column, John Goodman writes: "As governors across the land struggle with fiscal pressures and pepper the federal government with requests to scale back Medicaid - many people are losing sight of the fact that health care reform requires a huge expansion of Medicaid".
An online service that positions itself as the "Craigslist of biospecimens" aims to eliminate one of the most costly bottlenecks in biomedical R&D - delays in obtaining specimens suitable for research.
A malaria vaccine remains the most desired tool to combat the worsening malaria epidemic in many developing countries. Pierre Druilhe and colleagues (from the Institut Pasteur in Paris) have completed the first human trial of a vaccine based on MSP3, a protein present on the surface of the malaria parasite, with very encouraging results.
› Verified 8 days ago